Summary Report of the 21st Research Conference on Pulmonary Diseases of the Veterans Administration and the Armed Forces
THE 21ST RESEARCH CONFEBENCE on Pulmonary Diseases of the Veterans Administration and the Armed Forces met in St. Louis, Jan. 22-25, 1962. The change in the name of the conference from Chemotherapy of Tuberculosis, last year, reflects the increasing interest in nontuberculous pulmonary diseases. Fifty-two papers were presented, and these will be summarized along with pertinent comments which occurred during the discussion periods; however, the names of the individual authors will not be mentioned. Contributors included representatives from the cooperating Veterans Administration and Armed Forces hospitals, consultants, and guests. This is the tenth in a series of such reports.
Steroid Therapy—The first study, in which 8 Veterans Administration hospitals cooperated, was designed to determine the effect of steroid therapy on the incidence of favorable roentgenographic change, the disappearance of tubercle bacilli
Schwartz WS. Management of Common Pulmonary Diseases. JAMA. 1962;181(2):134-141. doi:10.1001/jama.1962.03050280064005i